BREZTRI AEROSPHERE

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Apr 27, 2026

   2 mo ago

2. Today

3. Exclusivity ends · NS

   New strength exclusivity (3 years)

   Apr 27, 2029

   in 2 yr 11 mo

4. Patent 10716753 expires

   Listed drug product patent expiration.

   May 28, 2030

   in 4 yr

5. Patent 8324266 expires

   Listed method-of-use patent (U-4503) expiration.

   May 28, 2030

   in 4 yr

6. Patent 8703806 expires

   Listed method-of-use patent (U-4503) expiration.

   May 28, 2030

   in 4 yr

7. Patent 8808713 expires

   Listed drug product patent expiration.

   May 28, 2030

   in 4 yr

8. Patent 9415009 expires

   Listed method-of-use patent (U-4503) expiration.

   May 28, 2030

   in 4 yr

9. Patent 9463161 expires

   Listed drug product patent expiration.

   May 28, 2030

   in 4 yr

10. Patent 8815258 expires

    Listed method-of-use patent (U-4503) expiration.

    Mar 17, 2031

    in 4 yr 10 mo

11. Patent 11331442 expires

    Listed drug product patent expiration.

    Oct 05, 2038

    in 12 yr 6 mo

12. Patent 11833292 expires

    Listed drug product patent expiration.

    Oct 05, 2038

    in 12 yr 6 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

• NSNew strength exclusivity (3 years)

  Apr 27, 2029

  in 2 yr 11 mo

Listed patents (9)